![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Steven N Singh. (2012) Costs and clinical consequences of suboptimal atrial fibrillation management. ClinicoEconomics and Outcomes Research 4, pages 79-90.
Read now
Read now
Alpesh N. Amin, Mehul Jhaveri & Jay Lin. (2012) Temporal pattern and costs of rehospitalization in atrial fibrillation/atrial flutter patients with one or more additional risk factors. Journal of Medical Economics 15:3, pages 548-555.
Read now
Read now
Anne B. Curtis. (2011) Update on the Clinical Management of Atrial Fibrillation: Guidelines and Beyond. Postgraduate Medicine 123:6, pages 7-20.
Read now
Read now
M.H. Kim, J. Lin, M. Hussein & D. Battleman. (2009) Incidence and economic burden of suspected adverse events and adverse event monitoring during AF therapy. Current Medical Research and Opinion 25:12, pages 3037-3047.
Read now
Read now
Chee W. Khoo & Gregory Y. H. Lip. (2009) Burden of atrial fibrillation. Current Medical Research and Opinion 25:5, pages 1261-1263.
Read now
Read now
Articles from other publishers (16)
Azka Latif, Amy M. Tran, Muhammad Junaid Ahsan, Fang Niu, Ryan W. Walters & Michael H. Kim. (2023) Relationship of health-related social needs and hospital readmissions in patients following a hospitalization for atrial fibrillation. American Heart Journal Plus: Cardiology Research and Practice 36, pages 100340.
Crossref
Crossref
Daisuke Miyazaki, Kunio Tarasawa, Kiyohide Fushimi & Kenji Fujimori. (2023) Risk Factors with 30-Day Readmission and the Impact of Length of Hospital Stay on It in Patients with Heart Failure: A Retrospective Observational Study Using a Japanese National Database. The Tohoku Journal of Experimental Medicine 259:2, pages 151-162.
Crossref
Crossref
Farah Yasmin, Muhammad Aamir, Abdul Moeed, Kinza Iqbal, Aymen Iqbal, Muhammad Sohaib Asghar, Waqas Ullah, Indranee Rajapreyar & Yevgeniy Brailovsky. (2023) Causes and Determinants of Heart Failure Readmissions Post Transcutaneous Aortic Valve Replacement: A Systematic Review and Meta-Analysis. Current Problems in Cardiology 48:1, pages 101428.
Crossref
Crossref
Anum Asif, Ahmet Sezer, Floyd Thoma, Catalin Toma, John Schindler, Jeffrey Fowler, Conrad Smith, Oscar C. Marroquin & Suresh R. Mulukutla. (2020) Relationship between predicting bleeding complication in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE‐DAPT) score and mortality among patients with atrial fibrillation undergoing percutaneous coronary intervention. Catheterization and Cardiovascular Interventions 98:5, pages 838-845.
Crossref
Crossref
Sherry Bumpus, Rachel Krallman, Colin McMahon, Ashwin Gupta, Daniel Montgomery, Eva Kline-Rogers & Prashant Vaishnava. (2020) Insights into hospital readmission patterns of atrial fibrillation patients. European Journal of Cardiovascular Nursing 19:6, pages 545-550.
Crossref
Crossref
A-Leum Han & Suhye Kwon. (2020) The Illness Adaptation Process of Patients Suffering from Atrial Fibrillation: Living a Life Managing the Silent Insurrection of the Heart. Korean Journal of Adult Nursing 32:3, pages 326.
Crossref
Crossref
Taylor-Jade Woods, Peter Speck & Billingsley Kaambwa. (2019) A systematic review protocol for examining 30-day readmission costs for atrial fibrillation patients. BMJ Open 9:10, pages e032101.
Crossref
Crossref
Hirofumi Hioki, Yusuke Watanabe, Ken Kozuma, Yugo Nara, Hideyuki Kawashima, Fukuko Nagura, Makoto Nakashima, Akihisa Kataoka, Masanori Yamamoto, Toru Naganuma, Motoharu Araki, Norio Tada, Shinichi Shirai, Futoshi Yamanaka & Kentaro Hayashida. (2017) Timing of Susceptibility to Mortality and Heart Failure in Patients With Preexisting Atrial Fibrillation After Transcatheter Aortic Valve Implantation. The American Journal of Cardiology 120:9, pages 1618-1625.
Crossref
Crossref
Barbara H. Johnson, Karen E. Smoyer-tomic, Kimberly Siu, David R. Walker, Stephen Sander, Dan Huse, David M. Smith, Xue Song & Alpesh Amin. (2013) Readmission among hospitalized patients with nonvalvular atrial fibrillation. American Journal of Health-System Pharmacy 70:5, pages 414-422.
Crossref
Crossref
Alpesh N. Amin, Mehul Jhaveri & Jay Lin. (2013) Hospital Readmissions in US Atrial Fibrillation Patients. American Journal of Therapeutics 20:2, pages 143-150.
Crossref
Crossref
Marilyn A. Prasun. (2012) Providing Best Practice in the Management of Atrial Fibrillation in the United States. Journal of Cardiovascular Nursing 27:5, pages 445-456.
Crossref
Crossref
MICHAEL H. KIM. (2012) Catheter Ablation of Atrial Fibrillation in Octogenarians: The Right “Medicine?”. Journal of Cardiovascular Electrophysiology 23:7, pages 694-696.
Crossref
Crossref
Gerald V. Naccarelli, Stephen S. Johnston, Mehul Dalal, Jay Lin & Parag P. Patel. (2012) Rates and Implications for Hospitalization of Patients ≥65 Years of Age With Atrial Fibrillation/Flutter. The American Journal of Cardiology 109:4, pages 543-549.
Crossref
Crossref
Marc Cohen & Catalin Boiangiu. (2011) The Management of Patients with Atrial Fibrillation and Dronedarone’s Place in Therapy. Advances in Therapy 28:12, pages 1059-1077.
Crossref
Crossref
Alpesh N. Amin, Mehul Jhaveri & Jay Lin. (2011) Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors. Advances in Therapy 28:10, pages 907-926.
Crossref
Crossref
Gerald V. Naccarelli, Stephen S. Johnston, Jay Lin, Parag P. Patel & Kathy L. Schulman. (2010) Cost Burden of Cardiovascular Hospitalization and Mortality in ATHENA‐Like Patients With Atrial Fibrillation/Atrial Flutter in the United States. Clinical Cardiology 33:5, pages 270-279.
Crossref
Crossref